Clinical Trials

A Phase 1/2 Dose Escalation and Cohort Expansion Study of LP-184 in Patients with Advanced or Metastatic Solid Tumors

Cancer Type

Solid Tumor

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Daruka Mahadevan, MD, PhD

For more information about this study
View Details

About This Study

To evaluate the safety, tolerability, MTD and the RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory to standard therapy or for whom no standard therapy is available.